Haw Par Corporation Limited

H02.SI : Singapore Exchange



Share Price in SGD. As of 28 May 17:04:20 SGT


Key stats

  • 52-Week High
    SGD 10.220
  • 52-Week Low
    SGD 9.110
  • Market Cap
    SGD 2.2B
  • Avg Volume
  • P/E Ratio (TTM)
  • Forward Dividend Yield

Share Price Performance

1 Day 0.10% 0.07%
5 Day 1.33% 0.67%
1 Month 2.80% 1.13%
6 Month 1.02% 8.62%
YTD 0.41% 3.10%
1 Year 3.12% -1.30%
5 Year -28.91% 0.89%
Include dividend return


Market Analysis

Consensus Share Price Target

No consensus on recommendation available. View analysis to learn more about Haw Par Corporation Limited.

Analyst Ratings

There is no analyst rating data currently available for Haw Par Corporation Limited.

Analyst Reports

There are no analyst reports currently available for Haw Par Corporation Limited.

Beansprout Insights


Price to earnings (P/E) ratio

Current P/E
Historical Average P/E

Haw Par Corporation Limited's current P/E ratio of ∞x is higher than its historical average P/E ratio of 16.6x.

Price to book (P/B) ratio

Current P/B
Historical Average P/B

Haw Par Corporation Limited's current P/B ratio of 0.6x is lower than its historical average P/B ratio of 0.8x.


Earnings per share (EPS)

The latest earnings per share is $0.98, which is higher than the earnings per share of $0.67 in 2022.


Financial Statements

26 Feb 2024

Full Yearly Results

For period ending 31 Dec 2023

11 Aug 2023

Half Yearly Results

For period ending 30 Jun 2023

Annual Reports

02 Apr 2024

Sustainability Report

For period ending 31 Dec 2023

02 Apr 2024

Annual Report

For period ending 31 Dec 2023



Company Description

Haw Par Corporation Limited, a Singapore-grown multinational Group, is listed on the Singapore Exchange since 1969. Over the decades, the Group has been disciplined in asset rationalisation, organically growing its core businesses, and making selected acquisitions. Today, the Haw Par Group is an enterprise with a strong consumer healthcare business that promotes healthy lifestyles through its healthcare products. The largest contributor to the healthcare business comes from a brand that it owns—Tiger Balm. With a wide range of products available in over 100 countries, Tiger Balm is arguably the world’s leading and most versatile topical analgesic brand. Besides the consumer healthcare business, the Group also engages in the leisure business and holds significant investments in securities and properties. Leveraging on its financial strength and global business network, the Group is well-placed in its strategic direction to further expand its portfolio of operating businesses and drive growth through alliances with multinational partners and acquisitions of complementary brands and compelling business platforms.


Hot stocks that may interest you